Genomma Lab Operating Margin vs. Revenue
| LABB Stock | MXN 25.59 0.19 0.74% |
For Genomma Lab profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Genomma Lab to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Genomma Lab Internacional utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Genomma Lab's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Genomma Lab Internacional over time as well as its relative position and ranking within its peers.
Genomma |
Genomma Lab Internacional Revenue vs. Operating Margin Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Genomma Lab's current stock value. Our valuation model uses many indicators to compare Genomma Lab value to that of its competitors to determine the firm's financial worth. Genomma Lab Internacional is currently regarded as number one stock in operating margin category among its peers. It also is considered the number one company in revenue category among its peers totaling about 78,296,557,128 of Revenue per Operating Margin. Comparative valuation analysis is a catch-all model that can be used if you cannot value Genomma Lab by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Genomma Lab's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Genomma Revenue vs. Operating Margin
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Genomma Lab |
| = | 0.20 % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Genomma Lab |
| = | 15.49 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Genomma Revenue vs Competition
Genomma Lab Internacional is considered the number one company in revenue category among its peers. Market size based on revenue of Health Care industry is now estimated at about 549.88 Billion. Genomma Lab holds roughly 15.49 Billion in revenue claiming about 2.82% of equities under Health Care industry.
Genomma Lab Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Genomma Lab, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Genomma Lab will eventually generate negative long term returns. The profitability progress is the general direction of Genomma Lab's change in net profit over the period of time. It can combine multiple indicators of Genomma Lab, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Genomma Lab Internacional, S.A.B. de C.V. together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico, the United States, and Latin America. Genomma Lab Internacional, S.A.B. de C.V. was founded in 1996 and is based in Mexico City, Mexico. GENOMMA LAB operates under Drug ManufacturersSpecialty Generic classification in Mexico and is traded on Mexico Stock Exchange. It employs 1451 people.
Genomma Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Genomma Lab. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Genomma Lab position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Genomma Lab's important profitability drivers and their relationship over time.
Use Genomma Lab in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Genomma Lab position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genomma Lab will appreciate offsetting losses from the drop in the long position's value.Genomma Lab Pair Trading
Genomma Lab Internacional Pair Trading Analysis
The ability to find closely correlated positions to Genomma Lab could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Genomma Lab when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Genomma Lab - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Genomma Lab Internacional to buy it.
The correlation of Genomma Lab is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Genomma Lab moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Genomma Lab Internacional moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Genomma Lab can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Genomma Lab position
In addition to having Genomma Lab in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Preferred Stock ETFs Thematic Idea Now
Preferred Stock ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Preferred Stock ETFs theme has 16 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Preferred Stock ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Genomma Stock Analysis
When running Genomma Lab's price analysis, check to measure Genomma Lab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genomma Lab is operating at the current time. Most of Genomma Lab's value examination focuses on studying past and present price action to predict the probability of Genomma Lab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genomma Lab's price. Additionally, you may evaluate how the addition of Genomma Lab to your portfolios can decrease your overall portfolio volatility.